Bingham Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Sell
1,486
-6
-0.4% -$2.05K 0.37% 80
2026
Q1
$525K Sell
1,492
-19
-1% -$6.77K 0.42% 73
2025
Q4
$495K Buy
+1,511
New +$479K 0.43% 75
2025
Q2
$393K Sell
1,407
-1
-0.1% -$283 0.37% 88
2025
Q1
$439K Buy
1,408
+305
+28% +$90.1K 0.45% 74
2024
Q4
$287K Buy
+1,103
New +$327K 0.31% 104

Other funds holding AMGN

Bingham Private Wealth's AMGN Position: Q2 2026 in Review

Bingham Private Wealth reduced its Amgen (AMGN) stake by 0.4% in Q2 2026, selling an estimated $2.05K and leaving 1,486 shares worth $538K. The position accounts for 0.37% of the portfolio, ranked #80.

Bingham Private Wealth first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bingham Private Wealth held 1,486 shares of Amgen worth $538K as of Q2 2026.
  • Bingham Private Wealth sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.37% of Bingham Private Wealth's portfolio in Q2 2026, its #80 holding.
  • Bingham Private Wealth first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.